1/8
11:28 am
snse
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Medium
Report
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.